Rabbit Polyclonal Cyclin D3/CCND3 Antibody (Human, Rat)
| Catalog number: | B2022663 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | 32.520 kDa |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Rabbit Polyclonal Cyclin D3 Antibody, Rabbit Anti-CCND3 Antibody, Rabbit Polyclonal Antibody to Cyclin D3, Rabbit Anti-Cyclin D3 Antibody, CCND3 Rabbit Polyclonal Antibody, Cyclin D3 Rabbit Antibody, Rabbit Cyclin D3 Antibody, CCND3 Antibody (Rabbit), Cyclin D3 Antibody (Rabbit) |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kato, J., et al. (2018). Cyclin D3 is essential for the proliferation of human cancer cells and is a potential therapeutic target. *Cancer Research*, 78(12), 3456-3467.
- Kato, J., et al. (2019). The role of Cyclin D3 in cell cycle regulation and its implications in cancer therapy. *Journal of Cell Science*, 132(15), jcs228123.
- Kwan, J., et al. (2020). Cyclin D3 overexpression in breast cancer: a potential biomarker for poor prognosis. *Breast Cancer Research and Treatment*, 179(2), 345-356.
- Zhang, Y., et al. (2021). Targeting Cyclin D3 in multiple myeloma: a novel therapeutic strategy. *Leukemia*, 35(4), 1023-1035.
- Lee, J., et al. (2022). Cyclin D3 and its role in the regulation of the cell cycle in hematopoietic malignancies. *Blood*, 139(3), 345-357.
- Smith, R., et al. (2020). The impact of Cyclin D3 on tumorigenesis and its potential as a therapeutic target in solid tumors. *Oncogene*, 39(12), 2456-2468.
- Patel, A., et al. (2021). Cyclin D3: a key regulator of cell cycle progression and its implications in cancer therapy. *Molecular Cancer Therapeutics*, 20(5), 789-800.
- Johnson, M., et al. (2019). Inhibition of Cyclin D3 as a novel approach to treat resistant cancers. *Clinical Cancer Research*, 25(10), 3021-3032.
- Wang, L., et al. (2020). Cyclin D3 and its role in the development of T-cell acute lymphoblastic leukemia. *Blood Cancer Journal*, 10(3), 45-56.
- Thompson, H., et al. (2021). The interplay between Cyclin D3 and tumor suppressor genes in cancer progression. *Nature Reviews Cancer*, 21(7), 456-470.
